After Mohs Surgery

New Orleans - A study of quality of life issues in patients with nonmelanoma skin cancer (NMSC) indicates that these patients have a high quality of life following treatment and also increase their use of sun-protective behaviors, said John S. Rhee, M.D., assistant professor of otolaryngology and communication sciences and dermatology, Medical College of Wisconsin, Milwaukee.

Related Videos
Related Content

Improve Patient Outcomes With Better Language Access

March 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Recent Povorcitinib 2b Study Shows Improved Repigmentation

March 27th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

Risankizumab Efficacious in Clearing, Improving Plaque Psoriasis

March 27th 2023

Improve Patient Outcomes With Better Language Access

March 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Recent Povorcitinib 2b Study Shows Improved Repigmentation

March 27th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

Risankizumab Efficacious in Clearing, Improving Plaque Psoriasis

March 27th 2023

Improve Patient Outcomes With Better Language Access

March 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Recent Povorcitinib 2b Study Shows Improved Repigmentation

March 27th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

Risankizumab Efficacious in Clearing, Improving Plaque Psoriasis

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.